Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05611099 · ClinicalTrials.gov registry record · NA
Robustness and Usability of the Dreem 3 System for at Home Sleep Monitoring in an Insomnia Population.
A NA study, sponsored by Dreem.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT05611099: Completed NA study, sponsored by Dreem.
NCT05611099 is a NA study that has completed, run by Dreem. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05611099, a NA study, has completed, sponsored by Dreem.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
There is an unmet medical need for monitoring sleep for multiple nights in a patient's home, without the inconvenience of traveling and staying overnight in a medical center, and without the need for a technician to set up a polysomnography (PSG) device at the patient's home. Several disorders, and particularly sleep disorders, are associated with insomnia symptoms, and longitudinal sleep assessment may support a better understanding and management of these patients, who currently seldom access sleep lab PSG. On one hand, this study aims at demonstrating whether the final device's user interface supports safe and effective use when being used at home over multiple nights. On the other, the study aims at confirming that stable and consistent data are measured in the device's actual use, for the records to be clinically usable in daily practice.
Primary Outcome
Pearson's Correlation between the total time (in minutes) the subject spends asleep (TST) as automatically determined by the Dreem 3S compared to the TST automatically determined by the WatchPAT One (WP1) device on the same night.
Interventions
- DEVICE Dreem 3 System vs WatchPAT One
- OTHER Usability Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-08-15 |
| Est. Completion | 2022-11-05 |
| Phase | NA |
What the finished NCT05611099 record still lists
NCT05611099 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Dreem 3 System vs WatchPAT One is the first listed.
NCT05611099 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05611099 about?
NCT05611099 is a clinical study titled "Robustness and Usability of the Dreem 3 System for at Home Sleep Monitoring in an Insomnia Population.". There is an unmet medical need for monitoring sleep for multiple nights in a patient's home, without the inconvenience of traveling and staying overnight in a medical center, and without the need for a technician to set up a polysomnography (PSG) device at the patient's home. Several disorders, and ...
What is the current status of trial NCT05611099?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2022-08-15. Estimated completion is 2022-11-05.
What interventions are being tested in trial NCT05611099?
The interventions under investigation include: Dreem 3 System vs WatchPAT One (DEVICE), Usability Questionnaire (OTHER).
Who is sponsoring clinical trial NCT05611099?
This trial is sponsored by Dreem, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05611099's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI